Evidence map›Paper›PMID 26931771›Full record

ArticleScientific reports2016

Innate myeloid cell TNFR1 mediates first line defence against primary Mycobacterium tuberculosis infection.

Noria Segueni, Sulayman Benmerzoug, Stéphanie Rose, Amandine Gauthier, Marie-Laure Bourigault, Flora Reverchon, Amandine Philippeau, François Erard, Marc Le Bert, Hélène Bouscayrol and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Genome-wide screen inbioRxiv : the preprint server for biology · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Household contact antigen-speciResearch square · 2024
    Article
  9. The balance between antiviral and antibacterial responses duringbioRxiv : the preprint server for biology · 2024
    Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Cytokine Receptors-Regulators of Antimycobacterial Immune Response.International journal of molecular sciences · 2022
    Review
  15. Trained immunity contributes to the prevention ofEmerging microbes & infections · 2021
    Review
  16. Article
  17. International journal of molecular sciences · 2021
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 4 countries.

Noria SegueniCNRS, UMR7355, Experimental and Molecular Immunology and Neurogenetics, 45071 Orleans, France.
Sulayman BenmerzougCNRS, UMR7355, Experimental and Molecular Immunology and Neurogenetics, 45071 Orleans, France.
Stéphanie RoseCNRS, UMR7355, Experimental and Molecular Immunology and Neurogenetics, 45071 Orleans, France.
Amandine GauthierUniversity of Orleans, 45000 Orleans, France.
Marie-Laure BourigaultCNRS, UMR7355, Experimental and Molecular Immunology and Neurogenetics, 45071 Orleans, France.
Flora ReverchonCNRS, UMR7355, Experimental and Molecular Immunology and Neurogenetics, 45071 Orleans, France.
Amandine PhilippeauCNRS, UMR7355, Experimental and Molecular Immunology and Neurogenetics, 45071 Orleans, France.
François ErardCNRS, UMR7355, Experimental and Molecular Immunology and Neurogenetics, 45071 Orleans, France.
Marc Le BertCNRS, UMR7355, Experimental and Molecular Immunology and Neurogenetics, 45071 Orleans, France.
Hélène BouscayrolOncology-radiotherapy Department, Regional Hospital, Orleans, France.
Thierry WachterOncology-radiotherapy Department, Regional Hospital, Orleans, France.
Irène GarciaDepartment of Pathology and Immunology, University of Geneva Medical School, Geneva, Switzerland.
George KolliasInstitute for Immunology, Biomedical Sciences Research Center "Alexander Fleming", Vari, Greece.
Muazzam JacobsDivision of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, Health Sciences Faculty, University of Cape Town, South Africa.
Bernhard RyffelCNRS, UMR7355, Experimental and Molecular Immunology and Neurogenetics, 45071 Orleans, France.
Valerie F J QuesniauxCNRS, UMR7355, Experimental and Molecular Immunology and Neurogenetics, 45071 Orleans, France.
Immunologie et Neurogénétique Expérimentales et Moléculaires · FRCentre National de la Recherche Scientifique · FRCentre hospitalier régional d'Orléans · FRAlexander Fleming Biomedical Sciences Research Center · GRNational Health Laboratory Service · ZAUniversité d'Orléans · FRUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TNF is crucial for controlling Mycobacterium tuberculosis infection and understanding how will help immunomodulating the host response. Here we assessed the contribution of TNFR1 pathway from innate myeloid versus T cells. We first established the prominent role of TNFR1 in haematopoietic cells for controlling M. tuberculosis in TNFR1 KO chimera mice. Further, absence of TNFR1 specifically on myeloid cells (M-TNFR1 KO) recapitulated the uncontrolled M. tuberculosis infection seen in fully TNFR1 deficient mice, with increased bacterial burden, exacerbated lung inflammation, and rapid death. Pulmonary IL-12p40 over-expression was attributed to a prominent CD11b(+) Gr1(high) cell population in infected M-TNFR1 KO mice. By contrast, absence of TNFR1 on T-cells did not compromise the control of M. tuberculosis infection over 6-months. Thus, the protective TNF/TNFR1 pathway essential for controlling primary M. tuberculosis infection depends on innate macrophage and neutrophil myeloid cells, while TNFR1 pathway in T cells is dispensable.

Indexed as

Immunity, InnateAnimalsBone Marrow CellsCytokinesLungMiceMice, KnockoutMycobacterium tuberculosisReceptors, Tumor Necrosis Factor, Type ITuberculosisCytokinesReceptors, Tumor Necrosis Factor, Type I

Identifiers

PMID26931771
PMCPMC4773807
OpenAlexW2325936797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.